|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Actavalon
| Actavalon 3210 Merryfield Row San Diego, CA 92121 | |
| | Year Established: | 2013 | Main Contact: | G. Wesley 'Wes' Hatfield, Ph.D., CEO | | Other Contacts: | Ned Israelsen, JD, Chairman & President Elena Dneprovskaia, Ph.D., CSO Michael S. Holzwarth, Ph.D., Director of Synthetic Chemistry
| | Company Description | Actavalon is a preclinical stage pharmaceutical company founded by private investors and faculty from the University of California Irvine and San Diego campuses. Actavalon focuses on the development of a single, broad spectrum, drug with the potential to target and eradicate human cancer cells of all types such as breast, lung, pancreatic, and colon cancer among others. | |
|
|
|
|
|